[4] On 15 March, Shri Mata Vaishnov Devi Shrine Board asked non-resident Indians and foreigners not to visit the temple for 28 days after landing in India.[8][9] Guidelines related to testing and quarantine protocols during the first wave included:[10] Categories exempted from the mandatory quarantine protocols included pregnant women, mothers with infants below 1yr; cancer, chronically ill and dialysis patients; children below 10 yrs travelling alone; GoI personnel on duty; Travelers with COVID negative test certificate issued by ICMR approved labs and not older than 48hrs; and CAPF and Armed forces personnel reporting for active duty in the Union Territory, will be sent to their respective formations.High-risk groups have been advised to take extra precautions or work from home and will not be attending frontline duties or involvement in public dealings.[27] On January 2, 2021, BBV152 (marketed as Covaxin), first indigenous vaccine, developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology received approval from the Drug Controller General of India for its emergency or conditional usage.[30] On 21 February, 2022, Drugs Controller General of India granted approval to Biological E's COVID-19 vaccine Corbevax, that can be used for children between 12–18 years of age.